Status: 03/25/2021 3:32 a.m.
According to a new study, the AstraZeneca vaccine is 76 percent effective. The federal vaccine commissioner expects a second German vaccine from the third quarter. All developments in the live blog.
More than 30 million corona cases in USA
More than 30 million confirmed cases have been recorded in the United States since the Covid-19 outbreak. According to a census by Johns Hopkins University, there were a total of 30,001,245 infections as of Wednesday (local time). The number of deaths related to the virus rose to more than 545,000. Nonetheless, there is cautious optimism among health experts. It is believed that 70 percent of citizens aged 65 or over have received at least one dose of vaccine. For the first time since November, the number of deaths per day averages less than 1,000 per day. Some states now allow anyone under the age of 16 to be vaccinated.
Vaccine officer expects a second German vaccine from the third quarter
The federal government’s vaccine commissioner expects a second German corona vaccine from the third quarter. “The government has high hopes for vaccine production by Curevac,” said Christoph Krupp to the newspapers of the Funke media group. If the European Medicines Agency (EMA) approves it as planned, “then we can use the Curevac vaccine from the second half of the year”.
Study: effectiveness of AstraZeneca at 76 percent
A new study confirms AstraZeneca’s vaccine is 76 percent effective against symptomatic Covid 19 diseases. AstraZeneca said, citing the analysis of current results from a broad US study, it would even completely prevent severe or critical processes.
Read Wednesday’s live blog